Dissociation of Phagocyte Recognition of Cells Undergoing Apoptosis from Other Features of the Apoptotic Program*
暂无分享,去创建一个
G. Cohen | V. Gogvadze | J. Savill | R. Snowden | J. Zhuang | Huijun Zhu | Yingyu Ren
[1] E. Alnemri,et al. Apoptosis in human monocytic THP.1 cells involves several distinct targets of N-tosyl-L-phenylalanyl chloromethyl ketone (TPCK) , 1997, Cell Death and Differentiation.
[2] G M Cohen,et al. Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.
[3] E. Alnemri,et al. Processing/Activation of At Least Four Interleukin-1β Converting Enzyme–like Proteases Occurs during the Execution Phase of Apoptosis in Human Monocytic Tumor Cells , 1997, The Journal of cell biology.
[4] Dean P. Jones,et al. Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.
[5] D. Green,et al. The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.
[6] D. H. Burgess,et al. Protease Involvement in Fodrin Cleavage and Phosphatidylserine Exposure in Apoptosis* , 1996, The Journal of Biological Chemistry.
[7] Seamus J. Martin,et al. Phosphatidylserine Externalization during CD95-induced Apoptosis of Cells and Cytoplasts Requires ICE/CED-3 Protease Activity* , 1996, The Journal of Biological Chemistry.
[8] Junying Yuan,et al. Human ICE/CED-3 Protease Nomenclature , 1996, Cell.
[9] G. Kroemer,et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease , 1996, The Journal of experimental medicine.
[10] S. Srinivasula,et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[11] G. Kroemer,et al. Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. , 1996, Journal of immunology.
[12] Xiaodong Wang,et al. Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.
[13] M. Castedo,et al. Mitochondrial control of nuclear apoptosis , 1996, Journal of Experimental Medicine.
[14] P. Henkart. ICE family proteases: mediators of all apoptotic cell death? , 1996, Immunity.
[15] S. Orrenius,et al. CPP32/Apopain Is a Key Interleukin 1 Converting Enzyme-like Protease Involved in Fas-mediated Apoptosis (*) , 1996, The Journal of Biological Chemistry.
[16] P. Williamson,et al. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes , 1995, The Journal of experimental medicine.
[17] D. Green,et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl , 1995, The Journal of experimental medicine.
[18] G. Cohen,et al. An ICE‐like protease is a common mediator of apoptosis induced by diverse stimuli in human monocytic THP.1 cells , 1995, FEBS letters.
[19] Patrick R. Griffin,et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.
[20] C. Thompson,et al. Apoptosis in the pathogenesis and treatment of disease , 1995, Science.
[21] Y. Lazebnik,et al. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE , 1994, Nature.
[22] G. Cohen,et al. Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukaemic cell line, U937. , 1994, Journal of cell science.
[23] C. Reutelingsperger,et al. Expression on B Cells Undergoing Apoptosis Annexin V for Flow Cytometric Detection of Phosphatidylserine , 2022 .
[24] N. Davidson,et al. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. , 1993, Cancer research.
[25] X. M. Sun,et al. Increased membrane permeability of apoptotic thymocytes: a flow cytometric study. , 1993, Cytometry.
[26] X. M. Sun,et al. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. , 1993, The Journal of biological chemistry.
[27] C. Haslett,et al. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. , 1992, Journal of immunology.
[28] X. M. Sun,et al. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. , 1992, The Biochemical journal.
[29] V. Fadok,et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. , 1992, Journal of immunology.
[30] S. Brown,et al. Analysis of the membrane potential of rat- and mouse-liver mitochondria by flow cytometry and possible applications. , 1990, European journal of biochemistry.
[31] N. Hogg,et al. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis , 1990, Nature.
[32] A. Wyllie. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation , 1980, Nature.
[33] M. Lavin,et al. The ICE family of cysteine proteases as effectors of cell death. , 1996, Cell death and differentiation.
[34] W. Earnshaw,et al. Nuclear changes in apoptosis. , 1995, Current opinion in cell biology.
[35] C. Haslett,et al. Phagocyte recognition of cells undergoing apoptosis. , 1993, Immunology today.
[36] A. Wyllie,et al. Apoptosis: mechanisms and roles in pathology. , 1991, International review of experimental pathology.